Newsletter Subject

The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Thu, Sep 26, 2024 10:43 PM

Email Preheader Text

Daily Headlines Thursday, September 26, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTL

[MEDPAGE TODAY]( Daily Headlines Thursday, September 26, 2024 Today's Top Stories for {NAME} [SPECIAL REPORTS]( [The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs]( [NEUROLOGY]( [NIH Neuroscience Leader Committed Research Misconduct, Agency Says]( [SPECIAL REPORTS]( [UVA Med School Faces Toxic Work Environment Allegations]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Beyond Transfusions: New and Emerging Therapies for Beta Thalassemia]( [PERSPECTIVES]( [How to Help Patients Save on Drug Costs]( [PEDIATRICS]( [Sudden Unexpected Infant Deaths Rose During the Pandemic]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [SPECIAL REPORTS]( [Prompt Engineering in Med School; Messages From Dr. ChatGPT; AI Scientist's Papers]( CME SPOTLIGHT [Unmasking von Hippel-Lindau (VHL) Disease: A Challenge in Clinical Recognition and Diagnosis]( [PSYCHIATRY]( [GLP-1 Agent May Hold Opioid Use Disorder Benefit]( [GASTROENTEROLOGY]( [Placebos Linked to Potential Harms in IBD Clinical Trials]( [POP MEDICINE]( [40-Hour Hurricane Hospital Shift; Giardia's Marketing Strategy; Complaining for Good]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Individualizing Advanced/Metastatic HER2+ Breast Cancer Care: Evidence-Based and Patient-Centered Approaches]( [DERMATOLOGY]( [Timely Skin Cancer Screening After Organ Transplant Still Lacking]( [PUBLIC HEALTH & POLICY]( [U.S. Health Authorities Need to Play Larger Role in Cannabis Policy, Report Says]( [PUBLIC HEALTH & POLICY]( [988 Calls Will Now Be Routed by Location Instead of Area Code]( CME SPOTLIGHT [Accelerating the Adoption of CAR T-Cell Therapy Into Clinical Practice for CLL Treatment]( [PSYCHIATRY]( [U.S. Suicides Held Steady in 2023 — At a Very High Level]( [ONCOLOGY/HEMATOLOGY]( [Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement]( [WASHINGTON WATCH]( [GOP Doctor Vying for House Seat in Kansas]( CME SPOTLIGHT [Transforming MM Management: Key Strategies for Infectious Disease Teams Using Bispecific Antibodies]( [SPECIAL REPORTS]( [Accused Doc: 'People Are Liars'; Hospital Settles Over Leaked Nude Patient Photos]( [RHEUMATOLOGY]( [These Kids With JIA Fare Poorly for Methotrexate Adherence]( [ASCO READING ROOM]( [Laura Bukavina, MD, MPH, MSc, on Financial Distress in Genitourinary Ca Survivors]( CME SPOTLIGHT [Empowering Historically Underrepresented Patients: Overcoming Healthcare Disparities in Multiple Myeloma]( [PUBLIC HEALTH & POLICY]( [Sickle Cell Disease Drug Pulled From Global Markets]( # Weekly Survey [Recommending New COVID Vaccines?]( The FDA authorized updated [mRNA]( and [non-mRNA]( COVID vaccines for the 2024-2025 respiratory virus season[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-09-26&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.